We are live on ! Find out more
KKRC

Kohlberg Kravis Roberts & Co Portfolio holdings

AUM $5.35B
1-Year Est. Return 63.01%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+63.01%
3 Year Est. Return
+297.95%
5 Year Est. Return
+219.08%
10 Year Est. Return
+856.54%
AUM
$8.12B
AUM Growth
+$1.54B
Cap. Flow
+$816M
Cap. Flow %
10.05%
Top 10 Hldgs %
85.43%
Holding
58
New
3
Increased
2
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
BBIO icon
BridgeBio Pharma
BBIO
+$1.01B
2
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
+$25.8M
3
SRCL
Stericycle Inc
SRCL
+$25.1M
4
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
+$12.5M
5
NEE.PRR
NextEra Energy, Inc.
NEE.PRR
+$10.2M

Top Sells

Rank Stock Value
1
GHY
PGIM Global High Yield Fund
GHY
+$8.77M
2
JRO
Nuveen Floating Rate Income Opportunty Fund
JRO
+$2.29M
3
LEA icon
Lear
LEA
+$260K

Sector Composition

Rank Sector Weight
1 Industrials 44.07%
2 Healthcare 13.14%
3 Technology 9.97%
4 Financials 6.13%
5 Real Estate 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IR icon
1
Ingersoll Rand
IR
$33.9B
$2.45B 30.12%
70,671,135
– –
BV icon
2
BrightView Holdings
BV
$1.3B
$1.09B 13.46%
58,418,246
– –
BBIO icon
3
BridgeBio Pharma
BBIO
$16.8B
$995M 12.26%
+36,900,661
New +$1.01B
PRAH
4
DELISTED
PRA Health Sciences, Inc.
PRAH
$664M 8.18%
6,695,984
– –
KREF
5
KKR Real Estate Finance Trust
KREF
$471M
$438M 5.4%
22,008,616
– –
SAIC icon
6
Saic
SAIC
$5.14B
$349M 4.3%
4,032,199
– –
EYE icon
7
National Vision
EYE
$1.75B
$281M 3.46%
9,149,908
– –
FOCS
8
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$260M 3.2%
9,523,809
– –
SONO icon
9
Sonos
SONO
$2B
$248M 3.05%
21,845,682
– –
LYFT icon
10
Lyft
LYFT
$5.87B
$161M 1.99%
2,456,952
– –
LAUR icon
11
Laureate Education
LAUR
$5.28B
$141M 1.74%
8,999,608
– –
COOP
12
DELISTED
Mr. Cooper
COOP
$118M 1.46%
14,773,245
– –
KKR icon
13
KKR & Co
KKR
$92.2B
$118M 1.45%
4,667,166
– –
MSGS icon
14
Madison Square Garden
MSGS
$9.58B
$85.4M 1.05%
427,705
– –
KRP icon
15
Kimbell Royalty Partners
KRP
$1.43B
$79.4M 0.98%
4,913,559
– –
CHRS icon
16
Coherus Oncology
CHRS
$222M
$67.5M 0.83%
3,055,055
– –
RNET
17
DELISTED
RigNet, Inc.
RNET
$50.4M 0.62%
5,000,254
– –
SRCL
18
DELISTED
Stericycle Inc
SRCL
$38.4M 0.47%
803,963
+493,963
+159% +$25.1M
BDXA
19
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
$29.4M 0.36%
475,000
+435,000
+1,088% +$25.8M
UXIN
20
Uxin Ltd
UXIN
$315M
$17.9M 0.22%
81,151
– –
DCUE
21
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
$12.4M 0.15%
+120,000
New +$12.5M
VICI icon
22
VICI Properties
VICI
$29.8B
$12.3M 0.15%
559,920
– –
NEE.PRR
23
DELISTED
NextEra Energy, Inc.
NEE.PRR
$10.5M 0.13%
+161,000
New +$10.2M
CZR
24
DELISTED
Caesars Entertainment Corporation
CZR
$5.91M 0.07%
500,000
– –
MR
25
DELISTED
Montage Resources Corporation Common Stock
MR
$4.5M 0.06%
736,989
– –
1
2

Similar funds

DPL
Danica Pension Livsforsikrings Copenhagen V $5.33B AUM 18.02% 1-Year Est. Return
LP
Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.38B AUM 6.22% 1-Year Est. Return
CBUSF
Construction & Building Unions Superannuation Fund Melbourne, Australia $5.31B AUM 20.68% 1-Year Est. Return
WL
WIT LLC District Of Columbia, District of Columbia $5.3B AUM 20.46% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return
FMWA
Forvis Mazars Wealth Advisors Springfield, Missouri $5.27B AUM 18.06% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Kohlberg Kravis Roberts & Co held 58 positions worth $8.12B, up 24% from $6.57B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Kohlberg Kravis Roberts & Co deployed $816M of net new capital in Q2 2019, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was BridgeBio Pharma: 36,900,661 shares worth $995M.

By sector, the portfolio is most concentrated in Industrials at 44% of assets, up from 43% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the most notable exit was PGIM Global High Yield Fund, an estimated $8.77M sold.

  • Kohlberg Kravis Roberts & Co's largest Q2 2019 buy was BridgeBio Pharma: 36,900,661 shares worth $995M.
  • Kohlberg Kravis Roberts & Co added most to Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 in Q2 2019, an estimated $25.8M increase.
  • Kohlberg Kravis Roberts & Co fully exited PGIM Global High Yield Fund in Q2 2019, selling an estimated $8.77M.
  • Kohlberg Kravis Roberts & Co's ten largest holdings make up 85% of its $8.12B portfolio in Q2 2019.
  • Kohlberg Kravis Roberts & Co opened 3 new positions and closed 3 in Q2 2019.
  • Kohlberg Kravis Roberts & Co's portfolio value rose 24% quarter-over-quarter to $8.12B.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q2 2019, filed 14 Aug 2019.